would be charged with the rapid and thorough assessment of the potential health risks suggested by reports of adverse events, identification and resolution of conflicts that may arise in the review of clinical trial and surveillance data, and the provision of expert advice on the maintenance and operation of effective postmarketing surveillance systems.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement